Regencell Bioscience Holdings Limited (RGC)
NASDAQ: RGC · Real-Time Price · USD
13.80
-1.25 (-8.31%)
At close: Jul 28, 2025, 4:00 PM
14.13
+0.33 (2.39%)
Pre-market: Jul 29, 2025, 7:04 AM EDT

Company Description

Regencell Bioscience Holdings Limited operates as a Traditional Chinese medicine (TCM) bioscience company in Hong Kong.

The company focuses on the research, development, and commercialization of TCM for the treatment of neurocognitive disorders and degeneration, primarily for attention deficit hyperactivity disorder and autism spectrum disorder.

Regencell Bioscience Holdings Limited was incorporated in 2014 and is headquartered in Causeway Bay, Hong Kong.

Regencell Bioscience Holdings Limited
Regencell Bioscience Holdings logo
CountryHong Kong
Founded2014
IPO DateJul 16, 2021
IndustryDrug Manufacturers - Specialty & Generic
SectorHealthcare
Employees12
CEOYat-Gai Au

Contact Details

Address:
Chinachem Leighton Plaza, 9th Floor
Causeway Bay
Hong Kong
Phone852 2155 0823
Websiteregencellbioscience.com

Stock Details

Ticker SymbolRGC
ExchangeNASDAQ
Fiscal YearJuly - June
Reporting CurrencyUSD
IPO Price$9.50
CIK Code0001829667
CUSIP NumberG7487R100
ISIN NumberKYG7487R1002
SIC Code2833

Key Executives

NamePosition
Yat-Gai AuFounder, Chairman and Chief Executive Officer
Michelle ChanFinancial Controller and Principal Financial Officer
Wai Hong ChungChief Operating Officer, Chief Strategy Officer and Director
Antonia AssangSenior Vice President of Project Management
Yat-Pui AuChief Business Officer

Latest SEC Filings

DateTypeTitle
Jul 11, 2025SCHEDULE 13D/AFiling
Jun 30, 20256-KReport of foreign issuer
Jun 30, 20256-KReport of foreign issuer
Jun 17, 20256-KReport of foreign issuer
Jun 2, 20256-KReport of foreign issuer
Mar 13, 2025SCHEDULE 13D/AFiling
Jan 15, 20256-KReport of foreign issuer
Oct 25, 202420-FAnnual and transition report of foreign private issuers
Jun 20, 20246-KReport of foreign issuer
Jan 2, 20246-KReport of foreign issuer